Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1939 1
1940 1
1941 1
1942 1
1943 2
1945 1
1946 5
1947 4
1948 4
1949 3
1950 5
1951 3
1952 5
1953 3
1954 6
1955 6
1956 6
1957 2
1958 3
1959 4
1960 5
1961 6
1962 3
1963 1
1964 2
1965 4
1966 8
1967 9
1968 7
1969 8
1970 8
1971 6
1972 13
1973 5
1974 12
1975 6
1976 10
1977 13
1978 8
1979 3
1980 16
1981 15
1982 8
1983 18
1984 15
1985 14
1986 11
1987 25
1988 14
1989 16
1990 19
1991 20
1992 22
1993 17
1994 36
1995 37
1996 37
1997 27
1998 33
1999 36
2000 35
2001 39
2002 47
2003 56
2004 57
2005 85
2006 83
2007 93
2008 94
2009 111
2010 118
2011 132
2012 124
2013 157
2014 156
2015 164
2016 166
2017 192
2018 176
2019 212
2020 262
2021 249
2022 237
2023 237
2024 247
2025 253
2026 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,953 results

Results by year

Filters applied: . Clear all
Page 1
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.
Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR. Mendell JR, et al. Among authors: murphy ap. Nat Med. 2025 Jan;31(1):332-341. doi: 10.1038/s41591-024-03304-z. Epub 2024 Oct 9. Nat Med. 2025. PMID: 39385046 Free PMC article. Clinical Trial.
Hepatoblastoma.
Pio L, O'Neill AF, Woodley H, Murphy AJ, Tiao G, Franchi-Abella S, Fresneau B, Watanabe K, Alaggio R, Lopez-Terrada D, Hiyama E, Branchereau S. Pio L, et al. Among authors: murphy aj. Nat Rev Dis Primers. 2025 May 22;11(1):36. doi: 10.1038/s41572-025-00620-7. Nat Rev Dis Primers. 2025. PMID: 40404742 Review.
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies.
Wu J, Bloch N, Chang AY, Bhavsar R, Wang Q, Crawford A, DiLillo DJ, Vazzana K, Mohrs K, Dudgeon D, Patel S, Ahmed H, Garg V, Amatulli M, Antao OQ, Yan Y, Wang S, Ramos W, Krueger P, Adler C, Ni M, Wei Y, Guo C, Macdonald L, Huang T, Ullman E, Hermann A, Yancopoulos GD, Murphy AJ, Davis S, Olson WC, Lin JC, Smith E, Zhang T. Wu J, et al. Among authors: murphy aj. Cell Rep Med. 2024 Oct 15;5(10):101747. doi: 10.1016/j.xcrm.2024.101747. Epub 2024 Sep 25. Cell Rep Med. 2024. PMID: 39326410 Free PMC article.
Phenotypic complexities of rare heterozygous neurexin-1 deletions.
Fernando MB, Fan Y, Zhang Y, Tokolyi A, Murphy AN, Kammourh S, Deans PJM, Ghorbani S, Onatzevitch R, Pero A, Padilla C, Williams SE, Flaherty EK, Prytkova IA, Cao L, Knowles DA, Fang G, Slesinger PA, Brennand KJ. Fernando MB, et al. Among authors: murphy an. Nature. 2025 Jun;642(8068):710-720. doi: 10.1038/s41586-025-08864-9. Epub 2025 Apr 9. Nature. 2025. PMID: 40205044
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone.
Dunn ME, Kithcart A, Kim JH, Ho AJ, Franklin MC, Romero Hernandez A, de Hoon J, Botermans W, Meyer J, Jin X, Zhang D, Torello J, Jasewicz D, Kamat V, Garnova E, Liu N, Rosconi M, Pan H, Karnik S, Burczynski ME, Zheng W, Rafique A, Nielsen JB, De T, Verweij N, Pandit A, Locke A, Chalasani N, Melander O, Schwantes-An TH; Penn Medicine Biobank; Baras A, Lotta LA, Musser BJ, Mastaitis J, Devalaraja-Narashimha KB, Rankin AJ, Huang T, Herman G, Olson W, Murphy AJ, Yancopoulos GD, Olenchock BA, Morton L. Dunn ME, et al. Among authors: murphy aj. Nature. 2024 Sep;633(8030):654-661. doi: 10.1038/s41586-024-07903-1. Epub 2024 Sep 11. Nature. 2024. PMID: 39261724 Free PMC article. Clinical Trial.
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202.
Vogel A, Sahai V, Hollebecque A, Vaccaro GM, Melisi D, Al Rajabi RM, Paulson AS, Borad MJ, Gallinson D, Murphy AG, Oh DY, Dotan E, Catenacci DV, Van Cutsem E, Lihou CF, Zhen H, Veronese ML, Abou-Alfa GK. Vogel A, et al. Among authors: murphy ag. ESMO Open. 2024 Jun;9(6):103488. doi: 10.1016/j.esmoop.2024.103488. Epub 2024 Jun 4. ESMO Open. 2024. PMID: 38838500 Free PMC article. Clinical Trial.
3,953 results